Home / CANCER BUZZ Podcast


Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple PodcastsSpotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Topic

Filter By Podcast Format

While advancements in oral medicine are improving the treatment landscape for head and neck cancer, routine dental care and preventative oral cancer screenings can help identify head and neck cancers early. In this episode, Alessandro Villa, DDS, PhD, MPH, chief of Oral Medicine, Oral Oncology, and Dentistry at Baptist Health South Florida’s Miami Cancer Institute, emphasizes the proactive role …
Advancements in clinical data and research have shown the immunotherapeutic potential of bispecific antibodies as treatment for hematologic cancers and solid tumors. In this episode, CANCER BUZZ speaks with Aaron Cumpston, PharmD, pharmacy clinical specialist in hematologic malignancies and bone marrow transplant and Christine Barrett, PharmD, BCOP, medical oncology clinical pharmacy specialist at …
In this episode, CANCER BUZZ speaks with Hilary Gee Goeckner, MSW, director of State and Local Campaigns for the American Cancer Society Cancer Action Network (ASC CAN), who shares policy perspectives and the latest on state legislation to expand coverage for biomarker testing for Medicaid beneficiaries.
In this episode, CANCER BUZZ speaks with Linda Hayward, patient financial advocate at the University of Maryland, Kaufman Cancer Center at Upper Chesapeake Health, about the challenges of treatment and strategies to address disparities in access and care for patients with acute myeloid leukemia.
The ACCC Oncology Reimbursement Meetings (ORMs) help all members of the multidisciplinary cancer care team navigate the annual changes in oncology reimbursement and regulations— while improving their knowledge on effective strategies for success in an everchanging oncology landscape. In this episode, CANCER BUZZ speaks with Jordan Karwedsky, financial counselor, Green Bay Oncology, about her …
Maintenance therapy for patients with acute myeloid leukemia, particularly those who are ineligible for transplant, can be critical to treatment outcomes and quality of life for patients. In this episode, CANCER BUZZ speaks with Thomas LeBlanc, MD, hematologic oncologist, associate professor of Medicine, and associate professor in Population Health Sciences at Duke Cancer Institute, about the importance …
On March 1, 2024, ACCC elected a new president and board of trustees for the 2024 -2025 term. CANCER BUZZ interviews outgoing President, Lekan Ajayi, and incoming President, Nadine Barrett, about their respective ACCC President’s Themes, the programs and resources ACCC developed in the past year, the state of the oncology workforce, ACCC’s role in improving health equity, the …
Live this week from the ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ interviews Krista Nelson, ACCC past president, about the new Institute for Comprehensive Cancer Care Services and resources for cancer centers to implement these services.
Live this week from the ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ interviews Dr. Sarah Hudson-DiSalle, member of the Reimbursement and Economics Subcommittee of ACCC’s Governmental Affairs Committee, about this week’s Hill Day, when members of ACCC met with Capitol Hill offices to advocate on behalf of patients.
Live this week from the ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ features an update from the White House on the Biden Cancer Moonshot program.
Live this week from the ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ interviews Dr. Mandi Pratt-Chapman about new patient navigation payments.
Live this week from the ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ interviews Wendi Waugh, ACCC financial navigation committee member, about resources for financial advocacy.
Recent advancements in treatment and a multimodal approach to care are improving outcomes for patients with head and neck cancer, however access to therapies and unique patient challenges due to disease symptoms, difficulty eating, difficulty communicating, and other psychosocial factors can reduce patient quality of life.
Founded in 2019, this inclusive lab is comprised of 42 members ranging from undergraduates to faculty from 12 different countries, most of whom self-identify as women and/or individuals who are under-represented in medicine.
In this podcast, Joy Larsen Haidle, Genetic Counselor at North Memorial Health Cancer Center in Robbinsdale, Minnesota, and Lillie Shockney, University Distinguished Service Professor of Breast Cancer, Professor of Surgery at Johns Hopkins University School of Medicine in Baltimore, Maryland, delve into the topic of BRCA mutation testing within breast cancer care, highlighting care gaps and opportunities …
In this podcast, Mila Felder, MD, FACEP, teases her keynote at the ACCC 50th Annual Meeting & Cancer Center Business Summit, why it’s important to attend this session in person, and what she’s looking forward to most at the meeting.
CANCER BUZZ spoke to Robin Atkins, RN, OCN, symptom triage nurse, Virginia Oncology Associates in Norfolk, Virginia. Listen as we discuss effective practices to support patients with diffuse large b-cell lymphoma throughout the care continuum.
As the use of chimeric antigen receptor (CAR) T-cell therapy continues to expand as an effective treatment for hematologic malignancies, understanding how to identify eligible patients early and implementation of an effective framework for identification can improve care coordination and better prepare community cancer programs for widespread use of CAR T-cell therapy.
The aging US population is predicted to drive an increase in cancer incidence of almost 50% by 2050. At the same time, some cancer programs face capacity and resource constraints—which will continue to increase as demand for cancer services rises. Many cancer programs are also facing significant challenges with patient access.
Health technology performance and integration of electronic health record (EHR) systems have become critical factors in conducting efficient and equitable biomarker testing at cancer programs nationwide.. Listen in as CancerBuzz speaks to Karen Huelsman, MS, LGC, precision oncology lead and genetic counselor at TriHealth Cancer and Blood Institute, about key takeaways and insights from the Working …
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.